SEARCH BY
Try For Free 7-Day Free Trial
RxPx provides digital risk management and patient adherence SaaS solutions in the specialty medicine sector, predominately in the Multiple Sclerosis (MS) market. It is focused on the commercialisation stage of the drug life cycle, assisting pharmaceutical companies on the launch and global roll out of new and in-market approved drugs. RxPx was founded in 2013 and is based in Sydney, Australia.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Software) | 1 of 1 |
Type (Merger) | 1 of 1 |
State (British Columbia) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2022) | 1 of 1 |